SCHEMBL3262155

SCHEMBL3262155

O=Cc1cc2cc(Cl)c(O)cc2oc1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 2/20 0.45
PPARG P37231 1/20 0.45
NCOA2 Q15596 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MCL1 Q07820 2/20 0.43
MAOB P27338 1/20 0.40
GPR35 Q9HC97 5/20 0.38
PON1 P27169 1/20 0.37
ERN1 O75460 3/20 0.36
MIF P14174 1/20 0.35
AKR1B1 P15121 2/20 0.35
CA12 O43570 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5377345 0.81 PTPN1 (0.50) NPSR1HPGDKDM4EALDH1A1MAPT
SCHEMBL15842309 0.79 HPGD (0.53) NPSR1HPGDKDM4EALDH1A1MAPT
SCHEMBL11621088 0.77 CA9 (0.56) NPSR1LMNAHPGDKDM4EALDH1A1
SCHEMBL11584039 0.77 NPSR1 (0.47) NPSR1HPGDKDM4EALDH1A1MAPT
SCHEMBL17942935 0.77 HSD17B3 (0.56) NPSR1LMNAPPARGNCOA2RXFP1
SCHEMBL7129765 0.75 MAOB (0.56) NPSR1LMNAPPARGNCOA2RXFP1
SCHEMBL14405907 0.74 MAOB (0.60) NPSR1LMNAPPARGNCOA2RXFP1
SCHEMBL530998 0.74 GPR35 (0.68) HPGDKDM4EALDH1A1MAOBGPR35
SCHEMBL1861098 0.73 HSD17B3 (0.60) NPSR1RXFP1HPGDKDM4EALDH1A1
SCHEMBL893041 0.73 KDM4E (0.61) NPSR1LMNAPPARGNCOA2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029017-A1 Mono-chlorinated hydroxycoumarin conjugates BECTON, DICKINSON AND COMPANY 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029017-A1 Mono-chlorinated hydroxycoumarin conjugates CLSPN, CLTC, HACD3 NPSR1 3458/4885LMNA 1910/4885PPARG 2878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.